# Grace Therapeutics, Inc.: Form 20-F for the period ended Feb 29, 2016

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 20-F
- Filed: 2016-05-31
- Accepted by EDGAR: May 31, 2016, 06:06 ET
- Period: 2016-02-29
- Accession: 0001102624-16-002894
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000110262416002894/acasti20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000110262416002894/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000110262416002894/acasti20f.htm

Filed May 31, 2016.
Source: SEC EDGAR, the filing index for accession 0001102624-16-002894. Last ingested by Listed: Nov 14, 2026, 23:10 ET. No prices; not investment advice.
